| Literature DB >> 35136434 |
Yohanes Budiarto1,2, Avin Fadilla Helmi1.
Abstract
Scholars agree that shame has many effects related to psychological functioning declines, and one among others is the fluctuation of self-esteem. However, the association between shame and self-esteem requires further studies. Heterogeneity studies due to different measurements, various sample characteristics, and potential missing research findings may result in uncertain conclusions. This study aimed to explore the relationship between shame and self-esteem by meta-analysis to come up with evidence of heterogeneity and publication bias of the study. Eighteen studies from the initial 235 articles involving the term shame and self-esteem were studied using the random-effects model. A total of 578 samples were included in the study. The overall effect size estimate between shame and self-esteem (r = -.64) indicates that shame correlates negatively with self-esteem and is large effect size. The result showed that heterogeneity study was found (I² = 95.093%). The Meta-regression showed that age moderated the relationship between shame and self-esteem (p = .002), while clinical sample characteristics (p = .232) and study quality (p = .184) did not affect the overall effect size.Entities:
Keywords: meta-analysis; meta-regression; publication bias; self-esteem; shame
Year: 2021 PMID: 35136434 PMCID: PMC8768475 DOI: 10.5964/ejop.2115
Source DB: PubMed Journal: Eur J Psychol ISSN: 1841-0413
Figure 1The Study Selection Process for Meta-Analysis Based on PRISMA Flow Diagram
The Quality Assessment Template of Chosen Studies
| Study: | First author: | |
|---|---|---|
| Date: | Journal: | |
| STUDY DESIGN | No | Yes |
| 1. Was the study prospective? | 0 | 1 |
| SAMPLE | ||
| 1. Was probability sampling used? | 0 | 1 |
| 2. Was the sample size justified? | 0 | 1 |
| 3. Was the sample drawn for more than one site? | 0 | 1 |
| 4. Was anonymity protected? | 0 | 1 |
| 5. The response rate was more than 60%? | 0 | 1 |
| MEASUREMENT | ||
| Shame [assess for shame correlated with self- esteem only] | ||
| 1. Was the outcome measured reliably | 0 | 1 |
| 2. Was the outcome measured using a valid instrument? | 0 | 1 |
| Influence on the measure of self-esteem? | ||
| 1. Was the dependent variable measured using a valid instrument? | 0 | 1 |
| 2. If a scale was used for measuring the dependent variable, was the internal consistency ≥ .70? | 0 | 2 |
| 3. Was a theoretical framework used for guidance? | 0 | 1 |
| STATISTICAL ANALYSIS | ||
| 1. If multiple outcomes were studied, are correlation analyzed? | 0 | 1 |
| 2. Were outliers managed? | 0 | 1 |
| Overall Study Validity Rating | TOTAL | |
Note. 0–4 = LO; 5–9 = MED; 10–14 = HI.
Summary of Quality Assessment of Each Study
| Standard | Number of studies | |
|---|---|---|
| Yes | No | |
| Design | ||
| Prospective study | 1 | 17 |
| Sample | ||
| Probability sampling | 0 | 18 |
| Proper sample size | 18 | 0 |
| Sample drawn for more than one site | 13 | 5 |
| Anonymity assurance | 11 | 7 |
| Response rate > 60% | 18 | 0 |
| Measurement | ||
| Reliable measures of outcomes | 18 | 0 |
| Valid measure of self-esteem | 18 | 0 |
| Valid measure of shame | 18 | 0 |
| Statistical Analysis | ||
| Correlation analysis when multiple effect studied | 17 | 1 |
| Management of outliers addressed | 0 | 18 |
Summary of Studies in the Meta-Analysis
| Study no. | Study name |
| Effect direction |
|
| Variance | Fisher's | 95% CI |
| Variance |
| Population characteristic |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
| 137 | Negative | −.17 | .08 | 0.007 | −0.17 | [−0.495,−0.258] | 0.09 | 0.007 | 11.50 | Clinical |
| 2 |
| 277 | Negative | −.36 | .05 | 0.003 | −0.38 | [−0.582,−0.103] | 0.06 | 0.004 | 22.57 | Nonclinical |
| 3 |
| 70 | Negative | −.33 | .11 | 0.012 | −0.34 | [−0.495,−0.258] | 0.12 | 0.015 | 20.54 | Nonclinical |
| 4 |
| 179 | Negative | −.56 | .05 | 0.003 | −0.63 | [−0.620,−0.325] | 0.07 | 0.006 | 27.20 | Clinical |
| 5 |
| 180 | Negative | −.43 | .06 | 0.004 | −0.47 | [−0.754,−0.601] | 0.07 | 0.006 | 27.20 | Clinical |
| 6 |
| 657 | Negative | −.59 | .02 | 0.001 | −0.68 | [−0.835,−0.402] | 0.04 | 0.002 | 34.89 | Nonclinical |
| 7 |
| 484 | Negative | −.63 | .03 | 0.000 | −0.74 | [−0.784,−0.503] | 0.05 | 0.002 | 28.40 | Clinical |
| 8 |
| 209 | Negative | −.57 | .05 | 0.002 | −0.65 | [−0.784,−0.511] | 0.07 | 0.005 | 21.66 | Nonclinical |
| 9 |
| 357 | Negative | −.33 | .05 | 0.002 | −0.34 | [−0.341,−0.002] | 0.05 | 0.003 | 21.19 | Nonclinical |
| 10 |
| 145 | Negative | −.55 | .06 | 0.003 | −0.62 | [−0.783,−0.454] | 0.08 | 0.007 | 26.01 | Nonclinical |
| 11 |
| 85 | Negative | −.55 | .08 | 0.006 | −0.62 | [−0.630,−0.339] | 0.11 | 0.012 | 13.55 | Nonclinical |
| 12 |
| 251 | Negative | −.51 | .05 | 0.002 | −0.56 | [−0.687,−0.438] | 0.06 | 0.004 | 28.50 | Nonclinical |
| 13 |
| 129 | Negative | −.42 | .07 | 0.005 | −0.45 | [−0.622,−0.273] | 0.09 | 0.008 | 31.00 | Nonclinical |
| 14 |
| 115 | Negative | −.68 | .05 | 0.003 | −0.83 | [−1.014,−0.644] | 0.09 | 0.009 | 24.13 | Nonclinical |
| 15 |
| 79 | Negative | −.98 | .05 | 0.000 | −0.30 | [−2.522,−2.073] | 0.11 | 0.013 | 36.49 | Clinical |
| 16 |
| 403 | Negative | −.83 | .01 | 0.000 | −0.19 | [−0.985,−0.789] | 0.05 | 0.003 | 23.90 | Nonclinical |
| 17 |
| 185 | Negative | −.45 | .06 | 0.003 | −0.48 | [−0.447,−0.239] | 0.07 | 0.005 | 21.00 | Nonclinical |
| 18 |
| 263 | Negative | −.48 | .05 | 0.002 | −0.52 | [−0.645,−0.401] | 0.06 | 0.004 | 34.60 | Nonclinical |
aFemale participants. bMale participants.
Heterogeneity Test Across Studies
|
|
|
|
|
|---|---|---|---|
| 95.09 | 346.44 | 17 | .000 |
Figure 2The Summary of Studies in the Meta-Analysis
Figure 3Funnel Plots of the Observed and Imputed Studies
The Orwin's Fail-Safe N Test
| Orwin's fail-safe | Criterion |
|---|---|
| Fisher's | −0.621 |
| The criterion for a trivial Fisher's | −0.600 |
| Mean Fisher's | 0.000 |
| Number of missing studies to bring Fisher's | 1.000 |
Rank Correlation Test for Funnel Plot Asymmetry
| Kendall's Tau |
| |
|---|---|---|
| −.03 | 0.15 | .439 (one-tailed) |
| .879 (two-tailed) |
Duval and Tweedie's Trim and Fill
| Value | Studies trimmed | Point estimate |
|
|
|
|---|---|---|---|---|---|
| Observed values | −0.643 | −0.784 | −0.502 | 346.444 | |
| Adjusted values | 7 | −0.812 | −0.962 | −0.663 | 741.736 |
Moderating Testing (Random Effects, REML Method)
| Covariate | Coefficient |
| 95% CI |
| ||
|---|---|---|---|---|---|---|
|
|
| |||||
| Intercept | −0.007 | 0.38 | −0.75 | 0.73 | −0.02 | .985 |
| Clinical characteristics | −0.229 | 0.19 | −0.61 | 0.15 | −1.20 | .232 |
| Study quality | 0.276 | 0.21 | −0.13 | 0.68 | 1.33 | .184 |
| Age | −0.031 | 0.01 | −0.06 | −0.01 | −2.42 | .015 |
Note. Simultaneous test: Q = 9.32, df = 3, p = .03.
Figure 4Regression Plot of Age as a Moderator